Business
Aidoc received the clearance for the commercial use of its triaging and notification algorithms for flagging and communicating incidental pulmonary embolism.
Hi, what are you looking for?
Aidoc received the clearance for the commercial use of its triaging and notification algorithms for flagging and communicating incidental pulmonary embolism.
Clal Biotechnology Industries Ltd. reported to the Tel Aviv Stock Exchange Today that its wound and burn care solutions unit MediWound Ltd. has been awarded...
Teva is the first applicant to receive approval and will have market exclusivity for generic Axert until November.
– – Israeli firm BiondVax, a biopharmaceutical company developing a Universal Flu Vaccine, announced that its Investigational New Drug Application (IND) for its Multimeric-001...
Women’s groups advocated for approval of the pill, Flibanserin – but others advised agency to remain cautious
The FDA is considering approval for a new drug called flibanserin.
Opko Health (NYSE: OPK; TASE: OPK), controlled by chairman Dr. Phillip Frost, has acquired EirGen Pharma, Ltd., a pharmaceutical company based in Ireland, focused on...
RegeneRx was recently allowed by the FDA to move into Phase III clinical trials with RGN-259 for the treatment of patients with NK.
Teva will pay Eagle $30 million upfront and up to $90 million in milestone payments.
– Two California counties have filed a law suit against a number of pharmaceutical companies for allegedly promoting pain killer addiction. – California’s Orange...